Literature DB >> 9665900

Eosinophilic pneumonia induced by dapsone.

D Jaffuel1, B Lebel, D Hillaire-Buys, J Pene, P Godard, F B Michel, J P Blayac, J Bousquet, P Demolyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9665900      PMCID： PMC28611          DOI： 10.1136/bmj.317.7152.181

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Adverse effects of dapsone.

Authors:  W R Graham
Journal:  Int J Dermatol       Date:  1975-09       Impact factor: 2.736

2.  Non-cardiogenic pulmonary oedema associated with pyrimethamine.

Authors:  J A Pang
Journal:  Respir Med       Date:  1989-05       Impact factor: 3.415

3.  Pulmonary toxicity of malaria prophylaxis.

Authors:  A C Davidson; C Bateman; C Shovlin; M Marrinan; G H Burton; I R Cameron
Journal:  BMJ       Date:  1988-11-12

4.  Pulmonary eosinophilia associated with dapsone.

Authors:  M Janier; L Guillevin; G Badillet
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321
  4 in total
  1 in total

1.  The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.

Authors:  Semaan G Kosseifi; Bhuvana Guha; Dima N Nassour; David S Chi; Guha Krishnaswamy
Journal:  J Occup Med Toxicol       Date:  2006-06-06       Impact factor: 2.646
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.